A drug named generically tofacitinib citrate which is in a class of drugs called

janus kinase inhibitors and which prevent the production of  cytokines  which

mediate inflammation is being used for a severe type of eczema called

atopic dermatitis.

Atopic Dermatitis is a type of skin inflammation characterized by itching,red and

cracked skin with a preponderance for the front of the knees and back of the

elbows.It has a definite genetic predisposition and many people with it are 

more prone to asthma and hay fever.

Janus kinase inhibitors (JAK) are also being proposed for psoriasis,vitiligo

(loss of skin pigment),and a type of hair loss called alopecia areata. 

In addition,janus kinase inhibitor drugs are used for rheumatoid arthritis.

Although generally well tolerated,janus kinase inhibitors can lead to 

opportunistic infections,malignancies,and elevated lipids(cholesterol,triglycerides).

Breaking News 

Disclaimer

The skin and medicine website is intended for educational purposes only and is not intended to treat, cure or diagnose your condition, nor is this information or products or treatments on this site to be used in lieu of consulting your physician or other qualified health care provider.